Research and experimental development in medical sciences and pharmacy (PKD 73.10.F)1997
Industry statistics (2025)
Number of companies
Companies
213
Companies (primary PKD)
14
Companies with financials
2
Business turnover
Stock market
No companies from this industry are listed.
Related PKD codes in division 73
FAQ
The primary industry for 14 companies is research and experimental development in medical sciences and pharmacy. 2 entities have filed financial statements.
In 2004, 6 new companies with PKD 73.10.F were registered. In all of 2003, there were 2 such companies.
In 2025, the median revenue for PKD 73.10.F was USD 637.55k and the mean revenue was USD 637.55k, based on 1 financial statement. Averages and medians include only companies that file financial statements, excluding sole proprietorships.
Yes, in 2025, the median net profit was USD 73.19k, an improvement on 2024 (USD -1.76k).